Cochrane Reviews - by sub-topics 'Peripheral Vascular Diseases'

Antiplatelets (0)

Beta-agonists (0)

Beta-blockers (0)

Blood transfusion (0)

Calcium antagonists (0)

Care (medical) during surgery (1)

Cerebrospinal fluid drainage for thoracic and thoracoabdominal aortic aneurysm surgery

Catecholamines (0)

Cell saver - use of (0)

Cytoprotectants (0)

Cerebrospinal fluid drainage (1)

Cytochromes (factors affecting cytochrome system) (0)

Fluids (1)

Intravenous fluids for abdominal aortic surgery

Graft types (2)

Endovascular repair of abdominal aortic aneurysm (protocol stage)

Graft materials for open abdominal aortic aneurysm repair (protocol stage) (withdrawn)

H2 blockers (0)

Haemodilution (0)

Heparin agonists (0)

Hydration - optimal pre-operative (0)

Incision - types of (0)

IV nutrition (0)

Lumbar sympathectomy (0)

Optiate antagonists (0)

Prostaglandins (0)

Pre-operative factors (not drugs or hydration) (0)

Sedatives (0)

Surgical techniques (3)

Endovascular repair of abdominal aortic aneurysm (protocol stage)

Endovascular treatment for ruptured abdominal aortic aneurysm

Surgery versus non-surgical treatment for femoral pseudoaneurysms

Surgery versus non-surgical treatment (3)

Endovascular repair of abdominal aortic aneurysm (protocol stage)

Surgery for small asymptomatic abdominal aortic aneurysms

Surgery versus non-surgical treatment for femoral pseudoaneurysms

Temperature (0)

Thromboxane antagonists (0)

Vasodilators (0)

Rehabilitation (0)

Acute limb ischaemia (5)

Prevention (0)

Treatment (5)

Medical treatments (1)

Anticoagulants (0)

Antibiotics (0)

Fibrinolytics (0)

Rheological agents (0)

Thrombolysis (1)

Surgery versus thrombolysis for initial management of acute limb ischaemia

Surgical treatments (4)

Amputations (2)

Criteria for determining level of amputation (0)

Flaps used in amputation (1)

Surgical techniques (1)

Surgery versus thrombolysis for initial management of acute limb ischaemia

Treatments given pre-, peri- or post-operatively (including following list to 'Vasodilators') (0)

Analgesics (0)

Anaesthetics (0)

Antibiotics (0)

Antipsychotics (0)

Antiplatelets (0)

Compression dressings (0)

Dressings (0)

Electromyostimulation (0)

Fibrinolytics (0)

Prostaglandins (0)

Phototherapy (0)

Vasodilators (0)

Anaesthetics used during surgery (0)

Drugs used pre-, peri- or post-operatively (1)

Beta-blockers (1)

Beta-adrenergic blockers for perioperative cardiac risk reduction in patients undergoing vascular surgery (protocol stage)

Surgical revascularisation (0)

Surgical thrombectomy (1)

Drugs used during surgical thrombectomy (0)

Rehabilitation (0)

Prostheses (0)

Rehabilitation methods (0)

Amputation (2)

Prevention (0)

Treatment (1)

Flaps used in amputation (1)

Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputation

Rehabilitation (1)

Aortic Dissection (1)

Endovascular versus conventional treatment for type B aortic dissection (protocol stage)

Aortic aneurysm, thoracic (3)

Treatment (3)

Cerebrospinal fluid drainage (1)

Cerebrospinal fluid drainage for thoracic and thoracoabdominal aortic aneurysm surgery

Surgical (2)

Thoracic stent graft versus surgery for thoracic aneurysm (protocol stage)

Thoracic stent graft versus surgery for traumatic thoracic transection (protocol stage)

Critical limb ischaemia (37)

Prevention (0)

Treatment (37)

Lifestyle treatments (3)

Diet (1)

Lipid-lowering for peripheral arterial disease of the lower limb

Exercise (1)

Lipid-lowering for peripheral arterial disease of the lower limb

Lipid lowering (1)

Medical treatments (4)

Amino acids (0)

Anticoagulants (0)

Analgesics (0)

Antibiotics (0)

Antiplatelets (0)

Buflomedil (0)

Dextran (0)

Haemodialysate (0)

Energy rich phosphates (0)

Fibrinolytics (0)

Gene therapy (0)

Herbal preparations (0)

Lipid lowering (1)

Lipid-lowering for peripheral arterial disease of the lower limb

Metabolic activators (0)

Methyl xanthines (0)

Naftidrofuryl (1)

Intravenous naftidrofuryl for critical limb ischaemia

Prostaglandins (1)

Prostanoids for critical limb ischemia (protocol stage)

Pentoxifylline (0)

Rutosides (0)

Serotonin antagonists (0)

Thrombolytics (1)

Thromboxane antagonists (0)

Vasodilators (0)

Vasospastic agents (0)

Surgical treatment (30)

Amputation (see 'Acute limb ischaemia' for details) (0)

Angioplasty (21)

Treatments/interventions during angioplasty (including following list to 'Prostaglandins') (3)

Angioplasty versus stenting for superficial femoral artery lesions (protocol stage)

Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)

Antibiotics (0)

Antiplatelets (0)

Buflomedil (0)

Haemostatic devices (0)

Oxygen supplementation (0)

Pre-operative drugs (0)

Prostaglandins (0)

Surgical techniques (including following list to 'Angioplasty versus other treatments') (3)

Angioplasty versus stenting for superficial femoral artery lesions (protocol stage)

Atherectomy for peripheral arterial disease (protocol stage)

Balloon dilatation (3)

Atherectomy for peripheral arterial disease (protocol stage)

Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)

Cryoplasty (1)

Closure techniques (0)

Laser recanalisation (1)

Atherectomy for peripheral arterial disease (protocol stage)

Guide wires (0)

Angipolasty versus other surgical techniques (4)

Angioplasty versus stenting for superficial femoral artery lesions (protocol stage)

Atherectomy for peripheral arterial disease (protocol stage)

Endovascular stents for intermittent claudication

Angioplasty versus non-surgical treatments (1)

Angioplasty (versus non surgical management) for intermittent claudication

Treatments/interventions to prevent restenosis following angioplasty (including following list to 'Prostaglandins') (0)

Anticoagulants (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Anaesthetics (0)

Antiplatelets (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Brachytherapy (1)

Intravascular brachytherapy for peripheral vascular disease

Dextran (0)

Essential fatty acids (0)

Haemodilution (0)

Lipid lowering (0)

Other treatments/interventions (1)

Endovascular stents for intermittent claudication

Prostaglandins (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Atherectomy (including endarterectomy and thromboendarterectomy) (2)

Atherectomy for peripheral arterial disease (protocol stage)

Bypass surgery (1)

Drugs used pre-, peri- or post-operatively (1)

Beta-adrenergic blockers for perioperative cardiac risk reduction in patients undergoing vascular surgery (protocol stage)

Spinal cord stimulation (2)

Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia

Stent insertion (2)

Atherectomy for peripheral arterial disease (protocol stage)

Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)

Sympathectomy (1)

Sympathectomy for peripheral arterial disease (protocol stage)

Rehabilitation (0)

Chronic venous insufficiency (14)

Prevention (3)

Compression (1)

Prevention of venous insufficiency in a standing workers population (protocol stage)

Exercise (1)

Prevention of venous insufficiency in a standing workers population (protocol stage)

Work place intereventions (1)

Prevention of venous insufficiency in a standing workers population (protocol stage)

Treatment (11)

Lifestyle treatments (3)

Exercise (1)

Physical treatments for non-complicated chronic venous insufficiency (protocol stage)

Education (1)

Physical treatments for non-complicated chronic venous insufficiency (protocol stage)

Counselling (1)

Physical treatments for non-complicated chronic venous insufficiency (protocol stage)

Medical treatments (5)

Anticoagulants (0)

Calcium antagonists (0)

Fibrinolytics (0)

Flavonoids (1)

Horse chestnut seed extract for chronic venous insufficiency

Herbal preparations (2)

Non-steroidal anti-inflammatories (0)

Rheological agents (0)

Ruscus extracts (0)

Rutosides (1)

Steroids (0)

Thrombolytics (0)

Topical treatments (0)

Venoactive agents (1)

Surgery for deep venous incompetence

Physical treatments (2)

Compression treatments (1)

Physical treatments for non-complicated chronic venous insufficiency (protocol stage)

Leg elevation (1)

Physical treatments for non-complicated chronic venous insufficiency (protocol stage)

Surgical treatments (1)

Rehabilitation (0)

Oedema (0)

Prevention (0)

Treatment (0)

Medical treatments (0)

Bradykinin antagonists (0)

Diuretics (0)

Herbal preparations (0)

Rutosides (0)

Saccharides (0)

Steroids (0)

Venoactive agents (0)

Physical treatments (0)

Compression (0)

Elevation of legs (0)

Rehablitation (0)

Peripheral arterial occlusive disease (PAOD) (75)

Prevention (0)

Treatment (75)

Lifestyle treatments (7)

Diet (2)

Lipid-lowering for peripheral arterial disease of the lower limb

Exercise (3)

Exercise for intermittent claudication

Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication

Lipid lowering (2)

Lipid-lowering for peripheral arterial disease of the lower limb

Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication

Medical treatments (27)

Amino acids (0)

Alpha blockers (0)

Anticoagulants (2)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

ACE inhibitors (0)

Alcohol (0)

Antioxidants (1)

Vitamin E for intermittent claudication

Antiplatelets (3)

Antiplatelet agents for intermittent claudication (protocol stage)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Cilostazol for peripheral arterial disease

Bamethane sulphate (0)

Bradykin antagonists (0)

Beta-blockers (2)

Beta blockers for peripheral arterial disease (protocol stage)

Beta-adrenergic blockers for perioperative cardiac risk reduction in patients undergoing vascular surgery (protocol stage)

Biguanides (0)

Blood pressure lowering drugs (0)

Buflomedil (1)

Buflomedil for intermittent claudication

Calcium antagonists (0)

Calcitonin (0)

Cerebral activator agents (1)

L-carnitine for intermittent claudication (protocol stage)

Chelation therapy (1)

Chelation therapy for atherosclerotic cardiovascular disease

Chemical sympathectomy (0)

Carbon dioxide (0)

Co-enzymes for vitamins (0)

Cytochromics (0)

Depropanox (0)

Dextran (0)

Essential fatty acids (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Energy rich phosphates (0)

Fibrinolytics (2)

Fibrinolytic agents for peripheral arterial occlusion (protocol stage)

Gene therapy (1)

Gene therapy for peripheral arterial disease (protocol stage)

Glucose metabolites (0)

Haemodialysate (0)

Haemodilution (0)

Herbal preparations (2)

Garlic for peripheral arterial occlusive disease

Ginkgo biloba for intermittent claudication (protocol stage)

Homocysteine-lowering interventions (1)

Homocysteine lowering interventions for peripheral arterial disease and bypass grafts

Hypoglycaemic agents (oral) (0)

Ifenprodil (0)

Lipid lowering (2)

Lipid-lowering for peripheral arterial disease of the lower limb

Naftidrofuryl for intermittent claudication

Monoamine oxidase inhibitors (0)

Methyl blue (0)

Methyldopa (0)

Methyl xanthine (0)

Narcain antagonists (0)

Nerve block (0)

Naftidrofuryl (1)

Neuroleptics (0)

Oestrogens (0)

Oxygen supplementation (0)

Ozone treatment (0)

Pantetheine (0)

Prostaglandins (2)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Prostanoids for intermittent claudication

Pentoxifylline (2)

Cilostazol for peripheral arterial disease

Pentoxifylline for intermittent claudication (protocol stage)

Rheological agents (0)

Rutosides (0)

Serotonin antagonists (0)

Suphonylurea (0)

Testosterone (1)

Steroid sex hormones for lower limb atherosclerosis

Thrombolytics (1)

Topical treatments (0)

Trace elements (0)

Thromboxane antagonists (0)

Vasodilators (0)

Vasospastic agents (0)

Physical treatments (0)

Electromagnetic field (diapulse) (0)

Electromyostimulation (0)

Immersion therapy (0)

Massage treatment (0)

Intermittent suction pressure treatment (0)

Surgical treatments (37)

Amputation (see 'Acute limb ischaemia' for details) (1)

Angioplasty (see 'Critical limb ischaemia' for details) (19)

Surgical techniques (including following list to 'Angioplasty versus other treatments') (4)

Angioplasty versus stenting for superficial femoral artery lesions (protocol stage)

Atherectomy for peripheral arterial disease (protocol stage)

Balloon angioplasty versus medical therapy for hypertensive patients with renal artery obstruction

Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)

Balloon dilatation (4)

Atherectomy for peripheral arterial disease (protocol stage)

Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)

Cryoplasty (1)

Angioplasty versus other surgical techniques (5)

Angioplasty versus stenting for superficial femoral artery lesions (protocol stage)

Atherectomy for peripheral arterial disease (protocol stage)

Endovascular stents for intermittent claudication

Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)

Angioplasty versus non-surgical treatments (1)

Angioplasty (versus non surgical management) for intermittent claudication

Treatments/interventions to prevent restenosis following angioplasty (including following list to 'Prostaglandins') (1)

Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)

Anticoagulants (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Antiplatelets (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Proastaglandins (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Atherectomy (including endarterectomy and thromboendarterectomy) (2)

Atherectomy for peripheral arterial disease (protocol stage)

Intravascular brachytherapy for peripheral vascular disease

Brachytherapy (1)

Bypass surgery (10)

Medical treatments/interventions pre-, peri- or post-operatively (including following list to 'Venoactive agents') (1)

Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery

Anticoagulants (1)

ACE inhibitors (0)

Anaesthesia (0)

Analgesics (0)

Antibiotics (1)

Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery

Antioxidants (0)

Antiplatelets (1)

Calcium antagonists (0)

Cholinergic agents (0)

Dextran (0)

Homocysteine-lowering interventions (1)

Homocysteine lowering interventions for peripheral arterial disease and bypass grafts

Intensive surveillance (0)

IV fluids (0)

Lipid lowering drugs (0)

Medical care during surgery (1)

Pentoxifylline (0)

Post-operative management (drains etc) (1)

Pre-operative hydration (0)

Pre-operative drugs (0)

Pre-operative factors (not drugs or hydration) (0)

Prostaglandins (0)

Temperature (0)

Thrombolysis (1)

Thromboxane antagonists (0)

Xanthine oxidase inhibitors (0)

Venoactive agents (0)

Surgical interventions (including following list to 'Types of sutures') (1)

Graft type for femoro-popliteal bypass surgery

Atherectomy of occluded bypass (0)

Thrombolysis with catheter (0)

Graft types (1)

Types of incision (0)

Lumbar sympathectomy (0)

Surgical techniques (0)

Types of sutures (0)

Spinal cord stimulation (1)

Infusion techniques for peripheral arterial thrombolysis

Stent insertion (2)

Atherectomy for peripheral arterial disease (protocol stage)

Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)

Thrombolysis with catheter (1)

Lumbar sympathectomy (0)

Venesection (0)

Treatment of complications associated with PAOD (4)

Prevention of restenosis/re-occlusion after treatment (4)

Anticoagulants (1)

Angioplasty (versus non surgical management) for intermittent claudication

Antiplatelets (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Fibrinolytics (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Prostaglandins (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Medical treatments (0)

Anticoagulants (0)

Antiplatelets (0)

Beta-blockers (0)

Blood pressure lowering drugs (0)

Calcium antagonists (0)

Serotonin antagonists (0)

Surgical treatments (0)

Lumbar sympathectomy (0)

Rehabilitation (0)

Thromboembolism (91)

Deep vein thrombosis (DVT) related (47)

Prevention (35)

Medical prophylaxis (18)

Anticoagulants (8)

Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair (protocol stage)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high risk patients (protocol stage)

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and MI) (protocol stage)

Interventions for preventing venous thromboembolism following abdominal aortic surgery

Interventions for preventing venous thromboembolism in adults undergoing knee athroscopy

Low molecular weight heparin for prevention of venous thromboembolism in patients with lower leg immobilization (protocol stage)

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Antioxidants (0)

Antithrombotics (4)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high risk patients (protocol stage)

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Interventions for preventing venous thromboembolism in adults undergoing knee athroscopy

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Antiplatelets (0)

Biguanides (0)

Calcium antagonists (0)

Chloroquine and derivatives (0)

Cyctotoxic/DNA reactive drugs (0)

Dextran (0)

Direct Thrombin Inhibitors (1)

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Fibrinolytics (0)

Immunosuppressants (0)

Indirect Thrombin Inhibitors (1)

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Non-steroidal anti-inflammatories (0)

Oestrogens (0)

Pentasaccharides (3)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high risk patients (protocol stage)

Interventions for preventing venous thromboembolism in adults undergoing knee athroscopy

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Polysaccharides (0)

Protease inhibitors (0)

Pentoxifylline (0)

Rheological agents (0)

Steroid hormones (0)

Testosterone/anabolic steroids (0)

Vasodilators (0)

Vitamin K Antagonists (1)

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Surgical prophylaxis (1)

Anaesthetic (0)

Cement (orthopaedic surgery) (0)

Catheter material (0)

Catheter location (0)

IV fluids (0)

Risk assessment (1)

Risk assessment versus no risk assessment for preventing deep vein thrombosis and pulmonary embolism in surgical patients (protocol stage) (withdrawn)

Tourniquet (0)

Physical methods of prophylaxis (15)

Compression (stockings) (7)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high risk patients (protocol stage)

Compression stockings for preventing deep vein thrombosis in airline passengers

Elastic compression stockings for prevention of deep vein thrombosis

Interventions for preventing venous thromboembolism in adults undergoing knee athroscopy

Knee length versus thigh length graduated compression stockings for prevention of deep vein thrombosis (protocol stage)

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)

Elevation of bed/feet (1)

Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)

Electromyostimulation (1)

Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)

Exercise (1)

Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)

Mechanical prophylaxis (4)

Interventions for preventing venous thromboembolism following abdominal aortic surgery

Interventions for preventing venous thromboembolism in adults undergoing knee athroscopy

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)

Mobilisation (1)

Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)

Other methods of prophylaxis (1)

Risk assessment (1)

Risk assessment versus no risk assessment for preventing deep vein thrombosis and pulmonary embolism in surgical patients (protocol stage) (withdrawn)

Treatment (12)

Medical treatment (12)

Anticoagulants (8)

Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism

Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism

Home versus in-patient treatment for deep vein thrombosis

Once versus twice daily LMWH for the initial treatment of venous thromboembolism

Subcutaneous unfractionated heparin for the treatment of venous thromboembolism (protocol stage)

Thrombolysis for acute deep vein thrombosis

Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism

Antiplatelets (0)

Biguanides (0)

Fibrinolytics (1)

Thrombolysis for acute deep vein thrombosis

Location of treatment (1)

Home versus in-patient treatment for deep vein thrombosis

Non-steroidal anti-inflammatories (1)

Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism

Pentasaccharides (0)

Polysaccharides (0)

Proteolytic enzymes (0)

Rheological agents (0)

Thrombolytics (1)

Thrombolysis for acute deep vein thrombosis

Surgical treatment (0)

Angioplasty (0)

Arterio-venous fistulae (0)

Filter insertion (0)

Surgical removal (0)

Thrombectomy (0)

Physical treatment (0)

Compression (0)

Mechanical treatment (0)

Idiopathic recurrent vein thrombosis (0)

Prevention (0)

Medical prophylaxis (0)

Anticoagulants (0)

Antiplatelets (0)

Biguanides (0)

Physical prophylaxis (0)

Compression (0)

Treatment (0)

Antiplatelets (0)

Not DVT related (3)

Prevention (3)

Anticoagulants (2)

Heparin-bonded catheters for prolonging the patency of central venous catheters in children

Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children (protocol stage)

Non-steroidal anti-inflammatories (0)

Physical prevention methods (1)

Heparin-bonded catheters for prolonging the patency of central venous catheters in children

Treatment (0)

Anticoagulants (0)

Non-steroidal anti-inflammatories (0)

Rehabilitation (0)

Post thrombotic syndrome (PTS) (7)

Prevention (4)

Medical prophylaxis (1)

Rutosides (1)

Rutosides for prevention of post thrombotic syndrome (protocol stage)

Physical methods of prophylaxis (3)

Compression (stockings) (1)

Non-pharmaceutical measures for prevention of post-thrombotic syndrome

Elevation of bed/feet (1)

Non-pharmaceutical measures for prevention of post-thrombotic syndrome

Mechanical prophylaxis (1)

Non-pharmaceutical measures for prevention of post-thrombotic syndrome

Treatment (3)

Compression (stockings) (1)

Compression therapy for treating stage I and II (Widmer) post-thrombotic syndrome

Mechanical treatment (1)

Compression therapy for treating stage I and II (Widmer) post-thrombotic syndrome

Medical (1)

Rutosides (1)

Rutosides for treatment of post-thrombotic syndrome (protocol stage)

Pulmonary Embolism (PE) (34)

Prevention (27)

Medical prophylaxis (20)

Anticoagulants (7)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high risk patients (protocol stage)

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Interventions for preventing venous thromboembolism following abdominal aortic surgery

Interventions for preventing venous thromboembolism in adults undergoing knee athroscopy

Low molecular weight heparin for prevention of venous thromboembolism in patients with lower leg immobilization (protocol stage)

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Vena caval filters for the prevention of pulmonary embolism

Antiplatelet agents (0)

Antithrombotics (6)

Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair (protocol stage)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high risk patients (protocol stage)

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Interventions for preventing venous thromboembolism in adults undergoing knee athroscopy

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Vena caval filters for the prevention of pulmonary embolism

Direct Thrombin Inhibitors (1)

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Indirect Thrombin Inhibitors (1)

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Pentasaccharides (3)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high risk patients (protocol stage)

Interventions for preventing venous thromboembolism in adults undergoing knee athroscopy

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Vitamin K antagonists (2)

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Vena caval filters for the prevention of pulmonary embolism

Physical methods of prophylaxis (6)

Compression (stockings) (3)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high risk patients (protocol stage)

Interventions for preventing venous thromboembolism in adults undergoing knee athroscopy

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Mechanical prophylaxis (3)

Interventions for preventing venous thromboembolism following abdominal aortic surgery

Interventions for preventing venous thromboembolism in adults undergoing knee athroscopy

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Surgical intervention (1)

Filter insertion (1)

Vena caval filters for the prevention of pulmonary embolism

Treatment (7)

Medical treatment (6)

Anticoagulants (3)

Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism

Subcutaneous unfractionated heparin for the treatment of venous thromboembolism (protocol stage)

Fibrinolytics (1)

Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism

Non-steroidal anti-inflammatories (1)

Pentasaccharides (0)

Thrombolytics (1)

Surgical treatment (1)